Overview

Drug-Drug Interaction Study of "CG100650" in Healthy Volunteers

Status:
Unknown status
Trial end date:
2019-12-30
Target enrollment:
Participant gender:
Summary
This is a randomized, open-label, multiple-dose, parallel, Phase 1 study to compare the pharmacokinetics and to evaluate Drug-Drug Interaction of "CG100650" in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
CrystalGenomics, Inc.
Treatments:
Tramadol